Incyte insider sales
WebMar 15, 2024 · Hedge Fund and Insider Trading News: Catherine Wood, Dan Loeb, Ray Dalio, Millennium Management, Chessica LP, Incyte Corporation (INCY), Verastem, Inc. (VSTM), and More. Billionaire investor Ray ... WebApr 12, 2024 · Morgan Stanley boosted their price objective on shares of Incyte from $76.00 to $77.00 in a research report on Wednesday. ... Insider Buying and Selling at Incyte. ... The stock was sold at an average price of $84.74, for a total value of $5,086,433.76. Following the sale, the executive vice president now owns 68,524 shares in the company ...
Incyte insider sales
Did you know?
WebApr 12, 2024 · Ballentine Partners LLC acquired a new position in shares of Incyte Co. ( NASDAQ:INCY - Get Rating) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 2,609 shares of the biopharmaceutical company's stock, valued at approximately $210,000. 3 S&P 500 … WebFeb 8, 2024 · Incyte Reports 2024 Fourth Quarter and Year-end Financial Results and Provides 2024 Financial Guidance and Updates on Key Clinical Programs ... 2024 reflects an increase in net product sales as a ...
WebApr 10, 2024 · INCY Complete Incyte Corp. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. WebMar 11, 2024 · The table below summarizes the most recent Incyte insider buying information, with links below the price to see the CAGR achieved by each insider on their …
WebInsider Trades - Track Insider Buying & Selling Today - Benzinga Learning where the insiders are buying and selling is just as important as building a trading strategy. When the insiders are... WebApr 15, 2024 · 3.00. Incyte currently has a consensus price target of $85.43, suggesting a potential upside of 14.67%. MaxCyte has a consensus price target of $10.50, suggesting a potential upside of 96.26% ...
WebApr 12, 2024 · Incyte Co. (NASDAQ:INCY – Get Rating)’s stock price gapped down prior to trading on Monday . The stock had previously closed at $75.51, but opened at $73.48. Incyte shares last traded at $74.04, with a volume of 102,254 shares. Wall Street Analysts Forecast Growth Several research analysts have issued reports on the company. Cowen increased […]
WebApr 15, 2024 · Insider Activity at Incyte In other Incyte news, EVP Maria E. Pasquale sold 60,024 shares of the firm’s stock in a transaction dated Monday, January 30th. The stock … list the five vital signsWebGet the latest updated list of insiders for Incyte Corporation (INCY). Find out the total of insider shares held, purchased and sold. list the five southern coloniesWebApr 15, 2024 · Incyte Trading Down 1.1 % NASDAQ INCY opened at $74.50 on Friday. Incyte Co. has a 52 week low of $65.07 and a 52 week high of $86.29. The company has a 50 day moving average price of $75.51... list the five types of white blood cellsWebMar 24, 2024 · Jakafi sales came in at $2.4 billion in 2024, contributing 71% to total revenues. Incyte has a collaboration agreement with Swiss pharma giant Novartis (. NVS … list the flow of blood through the heartWebFind the latest Insider Activity data for Incyte Corp. Common Stock (INCY) at Nasdaq.com. list the forces that can overcome keWeb151 rows · Get the latest insider transactions for Incyte Corporation (INCY). Find out the total of insider shares held, purchased and sold. Get the detailed quarterly/annual income statement for Incyte Corporation (INCY). … Discover historical prices for INCY stock on Yahoo Finance. View daily, weekly or … Find out all the key statistics for Incyte Corporation (INCY), including valuation … Find the latest Incyte Corporation (INCY) stock discussion in Yahoo Finance's … View the basic INCY option chain and compare options of Incyte Corporation … list the four basic types of enginesWebApr 15, 2024 · 3.00. Incyte presently has a consensus price target of $85.43, indicating a potential upside of 14.67%. MaxCyte has a consensus price target of $10.50, indicating a potential upside of 96.26% ... list the focus of your third paragraph